Kamada Ltd

NASDAQ:KMDA   3:59:49 PM EDT
4.58
-0.04 (-0.87%)
Products

AcuCort Signs Its First Commercial Agreement For Zeqmelit

Published: 11/23/2022 21:23 GMT
Kamada Ltd (KMDA) - Acucort Signs Its First Commercial Agreement for the Company's Drug Zeqmelit™.
Acucort Ab - Kamada's Assessment is That Co Will Be Able to Apply for Registration and Market Approval to Israeli Authority Moh in Q1 of 2023.
Acucort Ab - Agreement Gives Kamada Exclusive Right to Marketing and Sales As Well As Distribution of Zeqmelit in Israeli Market.